BCL2L1 anticorps (pSer62)
Aperçu rapide pour BCL2L1 anticorps (pSer62) (ABIN2617514)
Antigène
Voir toutes BCL2L1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pSer62
-
Specificité
- Recognizes endogenous levels of BCLX (pS62) protein.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
KLH-conjugated synthetic peptide encompassing a sequence within the central region of human BCLX (pS62).
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Approved: ICC (1:100 - 1:500), IF, IHC, IHC-P (1:100 - 1:200), WB (1:500 - 1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 0.01 % sodium azide, 30 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Aliquot to avoid freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot to avoid freeze/thaw cycles.
-
-
- BCL2L1 (BCL2-Like 1 (BCL2L1))
-
Autre désignation
- BCL2L1 / BCL-XL
-
Sujet
-
Name/Gene ID: BCL2L1
Family: Apoptosis
Synonyms: BCL2L1, Apoptosis regulator Bcl-X, Bcl-xL, BCL-XL/S, BCLXS, Bcl-2-like protein 1, BCL2-like 1, BCL2L, Bcl-X, Bcl-xS, BCLXL, PPP1R52, Bcl2-L-1, BCLX -
ID gène
- 598
-
Pathways
- Apoptose, Negative Regulation of intrinsic apoptotic Signaling
Antigène
-